Checklist for reporting a genetic association study

This checklist is relevant to studies reporting genetic associations and is based on the STREGA guidelines.  Read more


Complete now

Or download and complete offline

Instructions

Complete this checklist by entering the page numbers from your manuscript where readers will find each of the items listed below.

Your article may not currently address all the items on the checklist. Please modify your text to include the missing information. If you are certain that an item does not apply, please write "n/a" and provide a short explanation.

Download your completed checklist and include it as an extra file when you submit to a journal.

Title and abstract

1a

Title

Indicate the study’s design with a commonly used term in the title or the abstract. Read more

1b

Abstract

Provide in the abstract an informative and balanced summary of what was done and what was found. Read more

Background/rationale

2.

Explain the scientific background and rationale for the investigation being reported. Read more

Objectives

3.

State specific objectives, including any prespecified hypotheses. State if the study is the first report of a genetic association, a replication effort, or both. Read more

Study design

4.

Present key elements of study design early in the paper. Read more

Setting

5.

Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection. Read more

Eligibility criteria

6a

Cohort study – Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-up. Case-control study – Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controls. Cross-sectional study – Give the eligibility criteria, and the sources and methods of selection of participants. Give information on the criteria and methods for selection of subsets of participants from a larger study, when relevant. Read more

6b

Cohort study – For matched studies, give matching criteria and number of exposed and unexposed. Case-control study – For matched studies, give matching criteria and the number of controls per case. Read more

Variables

7a

Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable. Read more

7b

Clearly define genetic exposures (genetic variants) using a widely-used nomenclature system. Identify variables likely to be associated with population stratification (confounding by ethnic origin).

Data sources/measurement

8a

For each variable of interest give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group. Give information separately for for exposed and unexposed groups if applicable. Read more

8b

Describe laboratory methods, including source and storage of DNA, genotyping methods and platforms (including the allele calling algorithm used, and its version), error rates and call rates. State the laboratory / centre where genotyping was done. Describe comparability of laboratory methods if there is more than one group. Specify whether genotypes were assigned using all of the data from the study simultaneously or in smaller batches.

Bias

9a

Describe any efforts to address potential sources of bias. Read more

9b

Describe any efforts to address potential sources of bias. Read more

Study size

10.

Explain how the study size was arrived at. Read more

Quantitative variables

11.

Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen, and why. If applicable, describe how effects of treatment were dealt with. Read more

Statistical methods

12a

Describe all statistical methods, including those used to control for confounding. State software version used and options (or settings) chosen. Read more

12b

Describe any methods used to examine subgroups and interactions. Read more

12c

Explain how missing data were addressed. Read more

12d

If applicable, explain how loss to follow-up was addressed. Read more

12e

Describe any sensitivity analyses. Read more

12f

State whether Hardy-Weinberg equilibrium was considered and, if so, how.

12g

Describe any methods used for inferring genotypes or haplotypes.

12h

Describe any methods used to assess or address population stratification.

12i

Describe any methods used to address multiple comparisons or to control risk of false positive findings.

12j

Describe any methods used to address and correct for relatedness among subjects.

Participants

13a

Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed. Give information separately for for exposed and unexposed groups if applicable. Report numbers of individuals in whom genotyping was attempted and numbers of individuals in whom genotyping was successful. Read more

13b

Give reasons for non-participation at each stage. Read more

13c

Consider use of a flow diagram. Read more

Descriptive data

14a

Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders. Give information separately for exposed and unexposed groups if applicable. Consider giving information by genotype. Read more

14b

Indicate number of participants with missing data for each variable of interest. Read more

14c

Cohort study – Summarize follow-up time, e.g. average and total amount. Read more

Outcome data

15.

Cohort study Report numbers of outcome events or summary measures over time.Give information separately for exposed and unexposed groups if applicable. Report outcomes (phenotypes) for each genotype category over time Case-control study – Report numbers in each exposure category, or summary measures of exposure.Give information separately for cases and controls . Report numbers in each genotype category. Cross-sectional study – Report numbers of outcome events or summary measures. Give information separately for exposed and unexposed groups if applicable. Report outcomes (phenotypes) for each genotype category. Read more

Main results

16a

Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included. Read more

16b

Report category boundaries when continuous variables were categorized. Read more

16c

If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period. Read more

16d

Report results of any adjustments for multiple comparisons.

Other analyses

17a

Report other analyses done—e.g., analyses of subgroups and interactions, and sensitivity analyses. Read more

17b

Report other analyses done—e.g., analyses of subgroups and interactions, and sensitivity analyses. Read more

17c

Report other analyses done—e.g., analyses of subgroups and interactions, and sensitivity analyses. Read more

Key results

18.

Summarise key results with reference to study objectives.

Limitations

19.

Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias. Read more

Interpretation

20.

Give a cautious overall interpretation considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence. Read more

Generalisability

21.

Discuss the generalisability (external validity) of the study results. Read more

Funding

22.

Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based. Read more


To acknowledge this checklist in your methods, please state "We used the STREGA checklist when writing our report [citation]". Then cite this checklist as Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N; STrengthening the REporting of Genetic Association Studies. STrengthening the REporting of Genetic Association Studies (STREGA): An Extension of the STROBE Statement..


The STREGA checklist is distributed under the terms of the Creative Commons Attribution License CC-BY